Sintaho Pharmaceutical Ltd was established in the year of 2016 and headquartered in Chongqing China, with a grand vison of being the most trusted partner to pharmaceutical companies worldwide. We have a clear focus on developing and manufacturing highly potent and cytotoxic Active Pharmaceutical Ingredients (APIs) and CDMO services.
*The following content is generated by AI and is for reference only.
<h3>Overview</h3>
<p>EN-PNP (Enzyme-Linked Purine Nucleoside Phosphorylase) is not a standard commercial chemical product but refers to the enzymatic activity of Purine Nucleoside Phosphorylase used in diagnostic assays. No specific CAS number or molecular formula exists for this functional term as it denotes a biological catalyst rather than a synthetic compound.</p>
<h3>Application</h3>
<ul>
<li><strong>Diagnostics:</strong> Used in colorimetric and fluorometric kits for detecting purine metabolism disorders.</li>
<li><strong>Research:</strong> Essential for studying immunodeficiency mechanisms, particularly SCID associated with PNP deficiency.</li>
<li><strong>Drug Development:</strong> Serves as a target enzyme in screening inhibitors for leukemia therapies.</li>
</ul>
<h3>Precautions</h3>
<ul>
<li><strong>Safety:</strong> Handle recombinant enzymes with standard laboratory PPE; avoid skin contact.</li>
<li><strong>Storage:</strong> Maintain at -20°C to prevent denaturation; avoid repeated freeze-thaw cycles.</li>
<li><strong>Usage:</strong> Not intended for direct clinical administration; strictly for in vitro analytical use only.</li>
</ul>